Please assess the completion status of the following clinical trial:

Trial Title: Atorvastatin Effects On Arterial Stiffness In Hemodialysis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients on regular hemodialysis treatment for more than 3 months~Exclusion Criteria:~* Patients with diabetes mellitus.~* Patients with known severe valvular heart disease.~* Irregular heart rhythm.~* History of aortic surgery/prosthetic aorta.~* Acute liver disease.~* Patients receiving lipid lowering drugs.~* Pregnancy.~* History of myocardial infraction in the previous 6 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: EXPERIMENTAL): They will receive atorvastatin 10 mg, as one tablet /day for 24 weeks.
- placebo (Type: PLACEBO_COMPARATOR): They will receive a placebo in the form of multivitamin tablets similar to the experimental drug with the same regimen, as one tablet /day for 24 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).